title: Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.
abstract: Chemotherapy-induced peripheral neuropathy (CIPN) is a serious, painful and dose-limiting side effect of cancer drugs that target microtubules. The mechanisms underlying the neuronal damage are unknown, but may include disruption of fast axonal transport, an essential microtubule-based process that moves cellular components over long distances between neuronal cell bodies and nerve terminals. This idea is supported by the "dying back" pattern of degeneration observed in CIPN, and by the selective vulnerability of sensory neurons bearing the longest axonal projections. In this study, we test the hypothesis that microtubule-targeting drugs disrupt fast axonal transport using vesicle motility assays in isolated squid axoplasm and a cell-free microtubule gliding assay with defined components. We compare four clinically-used drugs, eribulin, vincristine, paclitaxel and ixabepilone. Of these, eribulin is associated with a relatively low incidence of severe neuropathy, while vincristine has a relatively high incidence. In vesicle motility assays, we found that all four drugs inhibited anterograde (conventional kinesin-dependent) fast axonal transport, with the potency being vincristine=ixabepilone>paclitaxel=eribulin. Interestingly, eribulin and paclitaxel did not inhibit retrograde (cytoplasmic dynein-dependent) fast axonal transport, in contrast to vincristine and ixabepilone. Similarly, vincristine and ixabepilone both exerted significant inhibitory effects in an in vitro microtubule gliding assay consisting of recombinant kinesin (kinesin-1) and microtubules composed of purified bovine brain tubulin, whereas paclitaxel and eribulin had negligible effects. Our results suggest that (i) inhibition of microtubule-based fast axonal transport may be a significant contributor to neurotoxicity induced by microtubule-targeting drugs, and (ii) that individual microtubule-targeting drugs affect fast axonal transport through different mechanisms.
authors.affiliation: Neuroscience Research Institute, University of California, Santa Barbara, CA 93106, USA.
authors.forename: Nichole E
authors.initials: NE
authors.lastname: LaPointe
authors.forename: Gerardo
authors.initials: G
authors.lastname: Morfini
authors.forename: Scott T
authors.initials: ST
authors.lastname: Brady
authors.forename: Stuart C
authors.initials: SC
authors.lastname: Feinstein
authors.forename: Leslie
authors.initials: L
authors.lastname: Wilson
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Jordan
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D001370:Axonal Transport / Q000187:drug effects*; D001369:Axons / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D034261:Epothilones / Q000633:toxicity*; D005663:Furans / Q000633:toxicity*; D007659:Ketones / Q000633:toxicity*; D016547:Kinesins / Q000378:metabolism*; D049834:Loligo; D008870:Microtubules / Q000187:drug effects* / Q000378:metabolism; D017239:Paclitaxel / Q000633:toxicity*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced* / Q000378:metabolism; D013997:Time Factors; D014404:Tubulin / Q000378:metabolism; D050257:Tubulin Modulators / Q000633:toxicity*; D014750:Vincristine / Q000633:toxicity*; D000095662:Polyether Polyketides
chemical_list: D000970:Antineoplastic Agents; D034261:Epothilones; D005663:Furans; D007659:Ketones; D016547:Kinesins; D017239:Paclitaxel; D014404:Tubulin; D050257:Tubulin Modulators; D014750:Vincristine; C430592:ixabepilone; C490954:eribulin; D000095662:Polyether Polyketides